Inventor · disambiguated record
Lars Röse
Also filed as: ROSE LARS · RÖSE LARS
9 granted patents·5 pending applications·12 citations·filing 2013–2022
81Inventor score
Top patents by PatentIndex Score
14 records- 0191US11795164B22-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancerBAYER AG·Filed 2022·Granted Oct 24, 2023·3 cites·8 claims
- 0278US11304946B22-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonistsBAYER AG·Filed 2018·Granted Apr 19, 2022·2 cites·11 claims
- 0377US11040035B23-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamidesBayer Pharma AG·Filed 2017·Granted Jun 22, 2021·2 cites·9 claims
- 0473US11655297B2ILDR2 antagonists and combinations thereofBAYER AG·Filed 2018·Granted May 23, 2023·1 cites·18 claims
- 0573US11459312B2Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamidesBAYER AG·Filed 2018·Granted Oct 4, 2022·2 cites·12 claims
- 0669US11517622B2Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancerBAYER AG·Filed 2019·Granted Dec 6, 2022·0 cites·24 claims
- 0768US11524944B22-phenylpyrimidine-4-carboxamides as AHR inhibitorsBAYER AG·Filed 2018·Granted Dec 13, 2022·1 cites·11 claims
- 0866US11591311B23-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamidesBAYER AG·Filed 2018·Granted Feb 28, 2023·1 cites·8 claims
- 0962US2022133888A1Combination of regorafenib and pd-1/pd-l1(2) inhibitors for treating cancerBAYER AG·Filed 2022·Application pending·0 cites
- 1053US11951166B2Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancerBAYER AG·Filed 2018·Granted Apr 9, 2024·0 cites·27 claims
- 1149US2022169736A1Combinations of anti-ildr2 antibodies and pd-1 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 1248US2023113037A1[1,2,4]triazolo[1,5-c]quinazolin-5-aminesBAYER AG·Filed 2020·Application pending·0 cites
- 1336US2015065472A1Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapyBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1436US2015119372A1Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disordersBayer Pharma AG·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Röse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →